These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26646274)

  • 1. Estimation of the Survival Benefit Obtainable From Screening for the Early Detection of Pancreatic Cancer.
    Cucchetti A; Ercolani G; Cescon M; Brandi G; Taffurelli G; Maroni L; Ravaioli M; Pezzilli R; Pinna AD
    Pancreas; 2016; 45(5):714-9. PubMed ID: 26646274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising outcomes of screening for pancreatic cancer by genetic testing and endoscopic ultrasound.
    Sud A; Wham D; Catalano M; Guda NM
    Pancreas; 2014 Apr; 43(3):458-61. PubMed ID: 24622079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for pancreatic cancer: why, how, and who?
    Poruk KE; Firpo MA; Adler DG; Mulvihill SJ
    Ann Surg; 2013 Jan; 257(1):17-26. PubMed ID: 22895395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis on expected years of life lost due to pancreatic cancer.
    Cucchetti A; Ercolani G; Taffurelli G; Serenari M; Maroni L; Pezzilli R; Del Gaudio M; Ravaioli M; Cescon M; Pinna AD
    Pancreatology; 2016; 16(3):449-53. PubMed ID: 26951889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.
    Cucchetti A; Trevisani F; Pecorelli A; Erroi V; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Giannini EG; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Baroni GS; Virdone R; Bernardi M; Pinna AD;
    J Hepatol; 2014 Aug; 61(2):333-41. PubMed ID: 24717522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quality of life is an important factor in the indication in patients with advanced pancreatic carcinoma--a prospective multicentric study].
    Ryska M; Dusek L; Pohnán R; Bunganic B; Bieberová L; Ryska O; Lovecek M; Jon B; Rupert K; Krejcí M; Jarkovský J
    Rozhl Chir; 2012 Apr; 91(4):199-208. PubMed ID: 22880267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
    Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
    JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that affect life expectancy of patients with gastric adenocarcinoma.
    Chen WY; Cheng HC; Wang JD; Sheu BS
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1595-600. PubMed ID: 23811250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
    Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
    JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.
    Hart SL; Torbit LA; Crangle CJ; Esplen MJ; Holter S; Semotiuk K; Borgida A; Ardiles P; Rothenmund H; Gallinger S
    Psychooncology; 2012 Dec; 21(12):1324-30. PubMed ID: 21774034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radical resection in patients with pancreatic head carcinomas. A retrospective survival analysis in a group of 307 subjects].
    Ryska M; Strnad R; Belina F; Zavoral M; Sálek C; Hrabal P; Buric I; Lásziková E; Kvicerová H; Jurenka B; Holcátová I
    Rozhl Chir; 2007 Aug; 86(8):432-9. PubMed ID: 17969981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model.
    Veronesi G; Maisonneuve P; Rampinelli C; Bertolotti R; Petrella F; Spaggiari L; Bellomi M
    Lung Cancer; 2013 Dec; 82(3):426-30. PubMed ID: 24099665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
    Chen PC; Lee JC; Wang JD
    PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study.
    Zubarik R; Gordon SR; Lidofsky SD; Anderson SR; Pipas JM; Badger G; Ganguly E; Vecchio J
    Gastrointest Endosc; 2011 Jul; 74(1):87-95. PubMed ID: 21704809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement.
    Abbott DE; Merkow RP; Cantor SB; Fleming JB; Varadhachary GR; Crane C; Bentrem DJ; Bilimoria KY
    Ann Surg Oncol; 2012 Nov; 19(12):3659-67. PubMed ID: 22965567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
    Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
    Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of pancreatic cancer.
    Eguia V; Gonda TA; Saif MW
    JOP; 2012 Mar; 13(2):131-4. PubMed ID: 22406583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
    Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.